Pharmaceutical companies are not the only ones out to influence our practice of medicine. Experts, insurance reviewers, advocacy groups, hospital administrators and, of course, patients and their families are just some of the people who would like us to do things a certain way. How can we successfully manage this? Dr. Steven Dubovsky, the Chairman of the Department of Psychiatry at the University of Buffalo joins host Dr. Leslie Lundt to discuss strategies.
Managing the Influence of Others
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Overview
Pharmaceutical companies are not the only ones out to influence our practice of medicine. Experts, insurance reviewers, advocacy groups, hospital administrators and, of course, patients and their families are just some of the people who would like us to do things a certain way. How can we successfully manage this? Dr. Steven Dubovsky, the Chairman of the Department of Psychiatry at the University of Buffalo joins host Dr. Leslie Lundt to discuss strategies.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Updates From the 7th World Symposium Task Force
Level Up Your Skills: Tailoring Management of HF
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?